(Q36359500)

13 August 2017

1 reference

title

Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension (English)

1 reference

13 August 2017

0 references

Teresa M Seccia

1

1 reference

PubMed ID

16390680

13 August 2017

Gian Paolo Rossi

series ordinal

2

1 reference

13 August 2017

1 January 2005

1 reference

Critical Reviews in Clinical Laboratory Sciences

13 August 2017

1 reference

13 August 2017

42

1 reference

13 August 2017

5-6

1 reference

13 August 2017

393-452

1 reference

Hypertension treatment and control in five European countries, Canada, and the United States

13 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Concept and usefulness of cardiovascular risk profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Urine microscopic analysis--an art abandoned by nephrologists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Hematuria: a simple method for identifying glomerular bleeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Value of urinary erythrocyte morphology in assessment of symptomless microhaematuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Evaluation of light microscopy to localise the site of haematuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The diabetes epidemic: a national and global crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

21 January 2018

Leptin and renal disease

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Early predictors of 15-year end-stage renal disease in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Renal function: the Cinderella of cardiovascular risk profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Measurement of renal function in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Limitations of creatinine as a filtration marker in glomerulopathic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Serum creatinine and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Serum cystatin C concentration as a marker of renal dysfunction in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Serum cystatin C as an index of renal function in kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Multicenter study of whole-blood creatinine, total carbon dioxide content, and chemistry profiling for laboratory and point-of-care testing in critical care in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Estimation of creatinine clearance when urine cannot be collected.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

An individual nomogram for determination of glomerular filtration rate from plasma creatinine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Nomogram for estimating creatinine clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Creatinine clearance estimation from serum creatinine values: an analysis of three mathematical models of glomerular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Comparison of methods of assessment of renal function in patients with cancer treated with cisplatin, carboplatin or methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Serum albumin for estimating creatinine clearance in the elderly with muscle atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Assessing renal function from creatinine measurements in adults with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The reliability of different formulae to predict creatinine clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Predicting glomerular function from adjusted serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Predictive performance of renal function estimate equations in renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prediction of GFR in liver transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Performance of different prediction equations for estimating renal function in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Measured and estimated GFR in healthy potential kidney donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Screening for renal disease using serum creatinine: who are we missing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria. Implications for micro- and macrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: the EPIC-Norfolk population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Laboratory Tests in Diagnosis and Management of Diabetes Mellitus. Practical Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Albumin to creatinine ratio: a screening test with limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria: associations with height and sex in non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The hypertensive patient with hypokalaemia: the search for hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

How to minimise factitious hyperkalaemia in blood samples from general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Human hypertension caused by mutations in WNK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Erythrocytosis: a key to understanding the hemodynamic changes in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Effect of hematocrit on blood pressure via hyperviscosity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The cardiovascular effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Non-high-density lipoprotein cholesterol and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Usefulness of non-high-density lipoprotein cholesterol determinations in the diagnosis and treatment of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

High-density lipoprotein--the clinical implications of recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prevalence of risk factors in men with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Lipoprotein-mediated cellular mechanisms for atherogenesis in hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The triglyceride connection in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Triglycerides and atherogenic lipoproteins: rationale for lipid management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Postprandial lipaemia in familial combined hyperlipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Laboratory-based assessment of plasma lipids and lipoproteins for the classification of familial hypercholesterolemic and hypertriglyceridemic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

High-density lipoprotein subclasses and apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Structure and function of apolipoprotein A-I and high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The effects of altered apolipoprotein A-I structure on plasma HDL concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Structure-function relationships of apolipoprotein A-I: a flexible protein with dynamic lipid associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Lipoprotein Lp(a) and atherothrombotic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Preventing cardiovascular events in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Etiology and prevalence of hypertension in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The importance of blood pressure control in the patient with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The clinical implications of impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

IFCC recommendation on reporting results for blood glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Management of dyslipidemia in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The metabolic syndrome and coronary heart disease in older women: findings from the British Women's Heart and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prognostic value of the metabolic syndrome in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Insulin resistance and the metabolic syndrome-a challenge of the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

A comparison of the prevalence of the metabolic syndrome using two proposed definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Metabolic syndrome: definition, pathophysiology, and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Insulin resistance: definition and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The role of the novel adipocyte-derived hormone adiponectin in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Role of Adiponectin in Insulin-Resistant Hypertension and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Novel clinical markers of vascular wall inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Hypertensive nephrosclerosis-a cause of end-stage renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Blood Pressure Predicts Risk of Developing End-Stage Renal Disease in Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The prognostic significance of proteinuria: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Proteinuria and progression in human glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Use of single voided urine samples to estimate quantitative proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Hyperuricemia and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Serum uric acid is not an independent risk factor for coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The syndrome of inappropriate antidiuretic hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Essential biochemistry and physiology of (NT-pro)BNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

NT-proBNP and BNP: biomarkers for heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

BNP in hormone-guided treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Fibrosis and hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Biochemical assessment of myocardial fibrosis in hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Monitoring fibrillar collagen turnover in hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Mediators produced by the endothelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Regulatory functions of the vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Nitric oxide. A novel signal transduction mechanism for transcellular communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

21 January 2018

NO: the primary EDRF.

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Nitric oxide as a signaling molecule in the vascular system: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Measurement of endothelin: clinical and research use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Systemic nature of endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Soluble CD40L and cardiovascular risk in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Correlation of NO metabolites and 8-iso-prostaglandin F2a with periventricular hyperintensity severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Cellular adhesion molecules and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Adhesion molecules and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

CD40 signaling and plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Soluble CD40L: risk prediction after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Superoxide in the vascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Inflammatory and oxidative markers in atherosclerosis: relationship to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Role of oxidative modifications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Biomarkers of vascular disease linking inflammation to endothelial activation: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Biochemistry of Nitric Oxide and Its Redox-Activated Forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Determination of nitrite/nitrate in human biological material by the simple Griess reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

A fluorometric assay for the measurement of nitrite in biological samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Homocysteine and cardiovascular disease: current evidence and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Hyperhomocysteinemia and its role in the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Genetic determinants of hyperhomocysteinaemia: the roles of cystathionine beta-synthase and 5,10-methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Homocysteine and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Cystathionine beta-synthase mutations in homocystinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Does homocysteine cause hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

High homocysteine levels are independently related to isolated systolic hypertension in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Total plasma homocysteine is associated with hypertension in Type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Molecular genetics of human blood pressure variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Genetically complex cardiovascular traits. Origins, problems, and potential solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Predicted Creatinine Clearance to Assess Glomerular Filtration Rate in Chronic Renal Disease in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Methylenetetrahydrofolate reductase gene polymorphism Relation to blood pressure and cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360500295600

10.1080/10408360500295600

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16390680